(36 days)
Not Found
No
The description focuses on mechanical verification and interlock based on electronic reading of the collimator, with no mention of AI/ML terms or image processing.
No
The device is described as an "accessory device indicated for use with a Linear Accelerator" to perform treatments, and its function is to provide secondary collimation and a security feature for radiation treatment, rather than directly providing therapy itself.
No
The device is described as an "accessory device indicated for use with a Linear Accelerator to perform Stereotactic Radiosurgery and precision Radiotherapy." Its function is to verify the correct selection of a conical collimator and prevent irradiation if it's out of conformance with the treatment plan. This indicates it's a treatment delivery and safety device, not one used for diagnosis.
No
The device description explicitly states that the system consists of hardware components: a collimator mount, conical collimators, and a locking ring.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for diagnostic, monitoring, or screening purposes.
- Device Function: The ICVI system is an accessory for a Linear Accelerator used in radiotherapy. Its function is to verify and interlock the correct selection of conical collimators for radiation treatment. It directly interacts with the radiation delivery system and the patient's body (indirectly, through the radiation beam), not with biological specimens.
- Intended Use: The intended use is to perform Stereotactic Radiosurgery and precision Radiotherapy on lesions or tumors. This is a therapeutic application, not a diagnostic one.
The device's purpose is to ensure the accurate delivery of radiation therapy, which is a treatment, not a diagnostic test performed on a sample outside the body.
N/A
Intended Use / Indications for Use
The Integrated Conical Collimator Verification and Interlock system (ICVI) is an accessory device indicated for use with a Linear Accelerator to perform Stereotactic Radiosurgery and precision Radiotherapy on intra-cranial and extra cranial lesions or tumors.
The Integrated Conical Collimator Verification and Interlock system is intended for use with a Linear Accelerator to perform Stereotactic Radiosurgery or precision Radiotherapy on intracranial and extra cranial lesions or turnors that require a conical collimator to shape the radiation beam.
Product codes (comma separated list FDA assigned to the subject device)
IYE
Device Description
Integrated Conical Collimator Verification and Interlock system (ICVI) is a secondary collimation system. It also has a security feature that verifies the correct selection of a conical collimator and prevents the radiation treatment device from commencing irradiation when the selected conical collimator is out of conformance with the treatment plan.
Integrated Conical Collimator Verification and Interlock system (ICVI) consists of a collimator mount that attaches to the accessory plate (Slot 2) of the linear accelerator, conical collimators that insert into the mount and are capable of being read electronically by the mount, and a locking ring that locks the conical collimator to the mount.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
intra-cranial and extra cranial lesions or tumors, benign or malignant
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Testing was performed to demonstrate
- That the device functions correctly with the specified Linear Accelerators.
- That the device meets mechanical specifications.
- Usability was assessed to the requirements of IEC 62366:2007.
Results of verification and validation testing showed conformance to applicable requirement specifications and assured hazard safeguards functioned properly.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.5050 Medical charged-particle radiation therapy system.
(a)
Identification. A medical charged-particle radiation therapy system is a device that produces by acceleration high energy charged particles (e.g., electrons and protons) intended for use in radiation therapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories.(b)
Classification. Class II. When intended for use as a quality control system, the film dosimetry system (film scanning system) included as an accessory to the device described in paragraph (a) of this section, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
K 123788
JAN 1 5 2013
510(k) Summary SUMMARY OF SAFETY AND EFFECTIVENESS
Integrated Conical Collimator Verification and Interlock system (ICVI)
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR 807.92(c).
Submitted by:
Varian Medical Systems, Inc. 3100 Hansen Way Palo Alto, CA 94304
Phone: 650-424-6320 Fax: 650-842-5040
Contact Person: Peter J. Coronado, Director, Regulatory Affairs
Date summary prepared: December 7, 2012
Trade Name: Integrated Conical Collimator Verification and Interlock system (ICVI)
Common Name: Integrated Conical Collimator Verification and Interlock system (ICVI)
Classification Name: Medical charged-particle radiation therapy system 21 CFR 892.5050, Class II Product Code: IYE
Predicate Devices: SNT Linac Accessories, K971893
Device Description:
Integrated Conical Collimator Verification and Interlock system (ICVI) is a secondary collimation system. It also has a security feature that verifies the correct selection of a conical collimator and prevents the radiation treatment device from commencing irradiation when the selected conical collimator is out of conformance with the treatment plan.
Integrated Conical Collimator Verification and Interlock system (ICVI) consists of a collimator mount that attaches to the accessory plate (Slot 2) of the linear accelerator, conical collimators that insert into the mount and are capable of being read electronically by the mount, and a locking ring that locks the conical collimator to the mount.
1
Indications for Use:
The Integrated Conical Collimator Verification and Interlock system (ICVI) is an accessory device indicated for use with a Linear Accelerator to perform Stereotactic Radiosurgery and precision Radiotherapy on intra-cranial and extra cranial lesions or turnors.
Intended Use:
The Integrated Conical Collimator Verification and Interlock system is intended for use with a Linear Accelerator to perform Stereotactic Radiosurgery or precision Radiotherapy on intracranial and extra cranial lesions or turnors that require a conical collimator to shape the radiation beam.
Characteristic | Predicate Device | Subject Device | Equivalent |
---|---|---|---|
SNT Linac Accessories, K971893 | Integrated Conical Collimator | ||
Verification and Interlock | |||
system (ICVI) | or Better? | ||
Intended Use | The SNT Linac Accessories are | ||
indicated for use with a Linear | |||
Accelerator to perform Stereotactic | |||
Radiosurgery or Radiotherapy on | |||
cranial lesions. The accessories | |||
include a secondary collimation | |||
system, components to mount a | |||
patient in a stereotactic headring to | |||
a linear accelerator's treatment | |||
couch, and components to position | |||
the patient relative to the isocenter | |||
of a linear accelerator in | |||
conjunction with a laser alignment | |||
system | The Integrated Conical | ||
Collimator Verification and | |||
Interlock system is intended | |||
for use with a Linear | |||
Accelerator to perform | |||
Stereotactic Radiosurgery or | |||
precision Radiotherapy on | |||
intra-cranial and extra cranial | |||
lesions or tumors that require | |||
a conical collimator to shape | |||
the radiation beam. | Yes | ||
Indications for | |||
Use | The SNT Linac Accessories are | ||
indicated for use with a Linear | |||
Accelerator to perform Stereotactic | |||
Radiosurgery or Radiotherapy on | |||
cranial lesions. The accessories | |||
include a secondary collimation | |||
system, components to mount a | |||
patient in a stereotactic headring to | |||
a linear accelerator's treatment | |||
couch, and components to position | |||
the patient relative to the isocenter | |||
of a linear accelerator in | |||
conjunction with a laser alignment system | The Integrated Conical | ||
Collimator Verification and | |||
Interlock system is an | |||
accessory device indicated for | |||
use with a Linear Accelerator | |||
to perform Stereotactic | |||
Radiosurgery and precision | |||
Radiotherapy on intra-cranial | |||
and extra cranial lesions or | |||
tumors. | Yes | ||
system | |||
Duration of Use | The patient would usually receive a | ||
series of treatments with a linear | |||
accelerator. | The patient would usually | ||
receive a series of treatments | |||
with a linear accelerator. | Yes | ||
Collimator | |||
mount | Yes | Yes | Yes |
Collimators | Yes, comes with collimators | Yes, comes with collimators | Yes |
Design | |||
Dimensions | Mount | ||
Not published | Mount | ||
476 x 350 x 100 mm without | |||
the conical collimator | |||
476 x 350 x 180 mm with the | |||
conical collimator | Yes | ||
Design | |||
Dimensions | Conical Collimators | ||
118 mm base diameter | |||
73 mm conical collimator | |||
diameter | |||
14 mm length | Conical Collimators | ||
118 mm base diameter | |||
73 mm conical collimator | |||
diameter | |||
14 mm length | Yes | ||
Design Material | Mount | ||
Not published | Mount | ||
Aluminum, Stainless Steel, | |||
Brass, Copper, PCB, Cabling | Yes | ||
Conical Collimators | |||
Tungsten & Aluminum | Conical Collimators | ||
Tungsten & Aluminum | |||
Anatomical | |||
Sites | Cranial lesions | Intra-cranial and extra-cranial | |
lesions or tumors, benign or | |||
malignant | Yes | ||
Mount & | |||
conical | |||
collimators | |||
electronically | |||
verifiable | No | Yes | Yes |
Provides | |||
verification that | |||
the correct | |||
conical | |||
collimator has | |||
been selected for | |||
patient treatment | |||
based on the | |||
patient's | No | Yes | Yes |
treatment plan. | |||
Patient Contact | None | None | Yes |
Biocompatibility | N/A no patient contact | N/A no patient contact | Yes |
Technological Characteristics:
2
.
:
.
.
.
3
Summary of Performance Testing:
Testing was performed to demonstrate
- That the device functions correctly with the specified Linear Accelerators .
- . That the device meets mechanical specifications
- Usability was assessed to the requirements of IEC 62366:2007 .
Results of verification and validation testing showed conformance to applicable requirement specifications and assured hazard safeguards functioned properly.
4
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002
January 15, 2013
Mr. Peter J Coronado Director, Regulatory Affairs Varian Medical Systems, Inc. 3100 Hansen Way PALO ALTO CA 94304
Re: K123788
Trade/Device Name: Integrated Conical Collimator Verification and Interlock System (ICVI)
Regulation Number: 21 CFR 892.5050 Regulation Name: Medical charged-particle radiation therapy system Regulatory Class: II Product Code: IYE Dated: December 7, 2012 Received: December 10, 2012
Dear Mr. Coronado:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
5
Page 2-Mr. Coronado
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Michael D. O'Hara
Janine M. Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
6
Indications for Use
510(k) Number (if known): K123788
Device Name: Integrated Conical Collimator Verification and Interlock System (ICVI)
Indications for Use:
The Integrated Conical Collimator Verification and Interlock system (ICVI) is an accessory device indicated for use with a Linear Accelerator to perform Stereotactic Radiosurgery and precision Radiotherapy on intra-cranial and extra cranial lesions or tumors.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Michael D. O'Hara
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
K123788 510(k) =======================================================================================================================================================================
Page 1 of